[Table/Fig-1]:

Distribution of hsa-miRNA gene polymorphisms.

S. No	Genotypes/Alleles	Controls (n=164)	Patients (n=184)	OR* (95%CI) p-value
miRNA 146a
1.	GG	84 (51.21%)	81 (44.02%)	Reference
2.	GC	72 (43.90%)	85 (46.19%)	1.218 (0.786-1.889)0.378
3.	CC	8 (4.87%)	18 (9.78%)	2.391 (0.982-5.818)0.055
	G	240 (73.17 %)	247 (67.11%)	Reference
	C	88 (26.82%)	121 (32.88%)	1.341 (0.966-1.861)0.079
miRNA 196a2
1.	CC	21 (12.80%)	20 (10.86%)	Reference
2.	CT	81 (43.90%)	93 (50.54%)	1.233 (0.622-2.444)0.548
3.	TT	62 (37.80%)	71 (38.58%)	1.234 (0.610-2.495)0.588
	C	123 (37.5%)	133 (36.14%)	Reference
	T	205 (62.5%)	235 (63.85%)	1.070 (0.785-1.457)0.669
miRNA 499
1.	TT	54 (32.9%)	26 (14.1%)	Reference
2.	CT	76 (46.34%)	78 (42.39%)	2.136 (1.214-3.757)0.008
3.	CC	34 (20.73%)	80 (43.47%)	4.801 (2.589-8.904)0.001
	C	144 (43.9%)	238 (64.6%)	Reference
	T	184 (56.0%)	130 (35.3%)	2.307 (1.619-3.131)0.001

*OR = odds ratio